Formulation of a liquid ovine Fab-based antivenom for the treatment of envenomation by the Nigerian carpet viper (Echis ocellatus)

Toxicon

Volumn 42, Issue 4, 2003, Pages 399-404

  Al Abdulla, Ibrahim ^a   Garnvwa, John M ^a   Rawat, Sophia ^b   Smith, David S ^a   Landon, John ^a   Nasidi, Abdulsalami ^c  

^a Newcastle Emlyn   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Federal Ministry of Health   (Nigeria)

Author keywords

Antivenom; Fab fragment; Formulation

Indexed keywords

BUFFER; IMMUNOGLOBULIN F(AB) FRAGMENT; MANNITOL; SNAKE VENOM; SODIUM CHLORIDE; SORBITOL; VENOM ANTISERUM;

ARTICLE; DRUG FORMULATION; DRUG POTENCY; DRUG STORAGE; ENVENOMATION; FREEZE DRYING; NIGERIA; PH; PRECIPITATION; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; TIME;

ECHIS; ECHIS OCELLATUS; ECHIS PYRAMIDUM; OVIS; OVIS ARIES;

EID: 0141560242     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(03)00170-3     Document Type: Article

References (18)

1. Allen G. The affinity of binding of digoxin to ovine anti-digoxin Fab (Digibind™) preparations. Biologicals. 24:1996;19-24.
2. Ariaratnam C.A., Sjostrom L., Raziek Z., Kularatne S.A.M., Arachchi R.W.K.K., Sheriff M.H.R., Theakston R.D.G., Warrell D.A. An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii). Trans. R. Soc. Trop. Med. Hyg. 95:2001;74-80.
3. Consroe P., Egen N.B., Russell F.E., Gerrish K., Smith D.C. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom induced lethality in mice. Am. J. Trop. Med. Hyg. 53:1995;507-510.
4. Curd J., Smith T.W., Jaton J.-C., Haber E. The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin. Proc. Natl. Acad. Sci. USA. 68:1971;2401-2406.
5. Decker W.W., Bogdan G.M., Garcia R.A., Wollen P., Dart R.C. Heat and motion stability of polyvalent Crotalidae antivenin ovine Fab. Toxicon. 36:1998;377-382.
6. European Pharmacopoeia, 1997. Strasbourg: Council of Europe.
7. Hill R.E., Bogdan G.M., Dart R.C. Time to reconstitution: purified Fab antivenom vs. unpurified IgG antivenom. Toxicon. 39:2001;729-731.
8. Johnstone A., Thorpe R. Immunochemistry in Practice. third ed:1996;Blackwell, Oxford. pp. 1-3.
9. Karlson-Stiber C., Persson H., Heath A., Smith D., Al-Abdullah I.H., Sjostrom L. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming. J. Int. Med. 241:1997;53-58.
10. Laing G.D., Lee L., Smith D.C., Landon J., Theakston R.D.G. Experimental assessment of a new low-cost antivenom for treatment of carpet viper (Echis ocellatus) envenoming. Toxicon. 33:1995;307-313.
11. Landon J., Smith D.S. Merits of sheep antisera for antivenom manufacture. J. Toxicol. Toxin Rev. 22:2003;15-22.
12. Meyer W.P., Habib A.G., Onayade A.A., Yakubu A., Smith D.C., Nasidi A., Daudu I.J., Warrell D.A., Theakston R.D.G. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (IPSER) Africa antivenom. Am. J. Trop. Med. Hyg. 56:1997;291-300.
13. Rawat S., Laing G., Smith D.C., Theakston D., Landon J. A new antivenom to treat Eastern coral snake (Micrurus fulvius fulvius) envenoming. Toxicon. 32:1994;185-190.
14. Rojas G., Espinoza M., Lomonte B., Gutiérrez J.M. Effect of storage temperature on the stability of the liquid polyvalent antivenom produced in Costa Rica. Toxicon. 29:1990;101-105.
15. Schumacher P. Aktuelle Fragen zur Haltbarkeit von Arzneimitteln. Pharmazeutische Zeitung. 119:1974;321-324.
16. Silver A.C., Smith D.S., Dawnay A. Accelerated-degradation testing of immunodiagnostic reagents. Clin. Chem. 33:1987;202.
17. WHO Technical Report Series No. 463. WHO Technical Report Series No. 463. 1971;World Health Organisation, Geneva. pp. 27-44.
18. WHO Offset Publication No. 58. WHO Offset Publication No. 58. 1981;World Health Organisation, Geneva.